M L KaytonSummaryAffiliation: National Institutes of Health Country: USA | Collaborators |
Detail Information
Publications
Endothelial monocyte activating polypeptide II (EMAP II) enhances the effect of TNF on tumor-associated vasculatureM L Kayton
Surgical Metabolism Section, Surgery Branch, National Cancer Institute, Bethesda, MD 20892, USA
Curr Opin Investig Drugs 2:136-8. 2001..By enhancing the tumor vasculature response to TNF, EMAP II may enable lower, non-toxic doses of TNF to be used to clinical advantage...
